MIP is a holistic behavioral intervention for
reducing high-risk behaviors for infection and transmission of HIV
among intravenous drug users (IDUs). The intervention is theory-driven
and intensive, combining individualized counseling and comprehensive
case management over a 3-6-month period. The strategies of motivational
counseling, self efficacy, and role induction are used.
Prerequisites for Training
For those
interested in participating in a MIP training of facilitators (TOF), it
is strongly recommended that participants have prior experience in
motivational interviewing and stages of change theory. All registered
participants will receive a survey to document their prior experience
in Motivational Interviewing. Priority will be given to individuals who
demonstrate prior course work and/or experience in Motivational
Interviewing and stages of change theory.
For an introductory course on Motivational Interviewing please consider contacting the Institute for Research, Education & Training in Addictions (IRETA) - you may visit http://ireta.org/webinars.
Research and Development
Robles R, Reyes J, Colon H, Sahai H, Marrero A, Matos T, Calderon J,
Shepard E. Effects of combined counseling and case management to reduce
HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A
randomized controlled study. Journal of Substance Abuse Treatment.
2004;27:145-152.
Marrero, CA, Robles RR, Colon HM, Reyes JC,
Matos TM, Sahai H., et al. Factors associated with drug treatment
dropout among injection drug users in Puerto Rico. Addictive Behaviors.
2005; 30:397-402.
Program Review Panel Information
The
CDC requires all CDC-funded agencies using the Modelo de Intervención Psicomédica
(MIP) intervention to identify, or establish, and utilize
a Program Review Panel and complete Form 0.1113 to document this
activity. The intervention researchers and developers are not involved
in this activity. This is a CDC requirement for their grantees, and all
questions in this regard should be directed to your agency's CDC
Project Officer or to the health department funding your agency's
implementation of the intervention.
The Program Review Panel guidlines, instructions for completion of Form 0.113, and the form itself are available under the Related Links section of this website.